ArticleMedicina (Kaunas, Lithuania)2026

Cardiovascular Outcomes Associated with Romosozumab Versus Denosumab in Chronic Kidney Disease.

Jheng-Yan Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.